Abstract
Background and Hypothesis Functional seizures (FS) are episodes characterized by seizure-like events that are not caused by hypersynchronous neuronal activity. Prior studies have suggested an increased prevalence of psychotic disorders among patients with FS, but results have been inconsistent. We hypothesize that FS are associated with psychosis and that among patients with psychosis, the presence of FS may influence patient clinical characteristics, mortality, and medical resource utilization.
Study Design The association between FS and psychosis was assessed using electronic health records data from a total of 752,883 individuals receiving care at Vanderbilt University Medical Center between 1989 and 2023. Analyses of the association between FS and psychiatric outcomes, sexual trauma, healthcare utilization, and other clinical comorbidities were conducted in a subset of 5,239 patients with psychosis.
Study Results Odds of FS were elevated among patients with psychosis compared to controls (OR=10.17, 95% CI=8.55-12.08, p<0.001). Among patients with psychosis, those with FS exhibited higher rates of suicidality (OR=1.98, 95% CI=1.40-2.8, p<0.001), catatonia (OR=1.95, 95% CI=1.23-3.09, p=0.03), sexual trauma history (OR=2.98, 95% CI=2.08-4.26, p<0.001) and had a greater numbers of antipsychotic trials (4.56 versus 3.37, beta=1.16, SE=0.16, p<0.001) than those without FS. Furthermore, patients with comorbid FS had a greater numbers of hospital presentations at one, three, five, and ten years after receiving a psychosis diagnosis (p<0.001).
Conclusions FS are more common among patients with psychosis and are associated with increased healthcare utilization as well as an increased prevalence of suicidality, catatonia, and certain psychiatric and medical comorbidities.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
The study received support from CTSA award no. UL1 TR002243 from the National Center for Advancing Translational Sciences, award no. UL1 TR000445 from the National Center for Advancing Translational Sciences, award no. F30 MH132165 from the National Institute of Mental Health (Lake), award no. T32 GM007347 from the National Institute of General Medical Sciences (Lake), and award no. R01 HG011405 (Davis), partially funded by the Office of Research on Women's Health, Office of the Director, NIH and the National Human Genome Research Institute. The contents of this study are solely the responsibility of the authors and do not necessarily represent official views of the funding agencies. The funding sources had no involvement in the preparation of this article.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This study was reviewed and approved by the Vanderbilt University Medical Center IRB (protocol #160650) and received a non-human subjects determination due to the use of de-identified electronic health records.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, University of Washington, and Vrije Universiteit Amsterdam.